Navigation Links
MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.
Date:6/16/2009

FREMONT, Calif., June 16 /PRNewswire/ -- Microfluidic Systems, a privately-held company, announced today that they received patent number 7,541,166, entitled "Sonication to Selectively Lyse Different Cell Types". This method, originally applied to the process of differential extraction of male/female DNA from a mixed forensic sample, has broad application in a wide variety of biological sample processes for analysis and identification. Combined with the companion patent number 7,491,527, "Microfluidic Differential Extraction Cartridge", it provides a complete solution to automate this complex sample processing method. The differential extraction technique is a key step in the identification of the perpetrator's DNA of a rape from a forensic sample. Performing this method in a closed, disposable, and automated cartridge ensures sample integrity and prevents human error, which is important to providing legal evidence in pursuing crimes. Similar requirements are pervasive in all biological sample processing applications.

"MFSI is pleased to further establish its proprietary position in this important sample processing technique," commented Dr. M. Allen Northrup, MFSI President and CEO. "It adds to our repertoire of microfluidic solutions to complex biological processing and analysis products," he added.

MicroFluidic Systems (MFSI), www.microfluidicsystems.com, was founded in 2001 and is focused on the development of microfluidic systems for automated preparation of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for the US Government and commercial markets for over 20 years, including the world's first miniaturized, portable, battery-operated, real-time, polymerase-chain-reaction (PCR)-based detection system. For more information, please contact MFSI at 510-354-0400 or visit the website, www.microfluidicsystems.com.

Statements in this press release are forward-looking. Actual results might differ from these statements due to unforeseen events and uncertainties. MFSI disclaims any intention to or obligation to update these forward-looking statements.


'/>"/>
SOURCE MicroFluidic Systems
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
2. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
3. GEN Reports on Growing Reliance on Microfluidics Technology
4. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
5. Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems
6. febit Receives U.S. Patent for Microfluidic Extraction Method
7. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
8. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives
9. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
10. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
11. Microfluidic chambers advance the science of growing neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):